Zhuo He

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Patient Reported Outcomes

Ejection Fraction

Prognostic Factors

Chronic Kidney Disease

Top Venues

ImmunoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Bin Duan, Xiao-Hui Wang, Guo-Can Zhang, Zhuo He, Shao-Qiang Li, Jie Zhou
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis. ImmunoTargets and therapy 13 (2024)
Wen-Bin Duan, Xiao-Hui Wang, Guo-Can Zhang, Zhuo He, Shao-Qiang Li, Jie Zhou
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis. ImmunoTargets and therapy 13 (2024)